Multiple Sclerosis Therapeutics Market, Global Outlook and Forecast 2023-2029

Report ID: MMG251137 | Category: Pharma & Healthcare | Pages: 69 | Format: PDF | Published Date: October 26,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between your brain and the rest of your body. Eventually, the disease can cause the nerves themselves to deteriorate or become permanently damaged.
This report aims to provide a comprehensive presentation of the global market for Multiple Sclerosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiple Sclerosis Therapeutics. This report contains market size and forecasts of Multiple Sclerosis Therapeutics in global, including the following market information:
Global Multiple Sclerosis Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Multiple Sclerosis Therapeutics market was valued at US$ 17530 million in 2022 and is projected to reach US$ 20010 million by 2029, at a CAGR of 1.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Beta Interferon Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Multiple Sclerosis Therapeutics include Novartis, Teva Pharmaceuticals, Sanofi Genzyme, Bayer, Pfizer, Biogen Idec, Merck and AbbVie, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Multiple Sclerosis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Multiple Sclerosis Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Multiple Sclerosis Therapeutics Market Segment Percentages, by Type, 2022 (%)
    Beta Interferon
    Corticosteroids
    Monoclonal Antibodies
    Antineoplastic Agents
    Others
Global Multiple Sclerosis Therapeutics Market, by Distribution Channel, 2018-2023, 2024-2029 ($ millions)
Global Multiple Sclerosis Therapeutics Market Segment Percentages, by Distribution Channel, 2022 (%)
    Hospital Pharmacies
    Retail Pharmacies
    e-Commerce
Global Multiple Sclerosis Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Multiple Sclerosis Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Multiple Sclerosis Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Multiple Sclerosis Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Novartis
    Teva Pharmaceuticals
    Sanofi Genzyme
    Bayer
    Pfizer
    Biogen Idec
    Merck
    AbbVie
Outline of Major Chapters:
Chapter 1: Introduces the definition of Multiple Sclerosis Therapeutics, market overview.
Chapter 2: Global Multiple Sclerosis Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Multiple Sclerosis Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by distribution channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Multiple Sclerosis Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Multiple Sclerosis Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Distribution Channel
    1.3 Global Multiple Sclerosis Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Multiple Sclerosis Therapeutics Overall Market Size
    2.1 Global Multiple Sclerosis Therapeutics Market Size: 2022 VS 2029
    2.2 Global Multiple Sclerosis Therapeutics Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Multiple Sclerosis Therapeutics Players in Global Market
    3.2 Top Global Multiple Sclerosis Therapeutics Companies Ranked by Revenue
    3.3 Global Multiple Sclerosis Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Multiple Sclerosis Therapeutics Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Multiple Sclerosis Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Multiple Sclerosis Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Multiple Sclerosis Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Multiple Sclerosis Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Multiple Sclerosis Therapeutics Market Size Markets, 2022 & 2029
        4.1.2 Beta Interferon
        4.1.3 Corticosteroids
        4.1.4 Monoclonal Antibodies
        4.1.5 Antineoplastic Agents
        4.1.6 Others
    4.2 By Type - Global Multiple Sclerosis Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Multiple Sclerosis Therapeutics Revenue, 2018-2023
        4.2.2 By Type - Global Multiple Sclerosis Therapeutics Revenue, 2024-2029
        4.2.3 By Type - Global Multiple Sclerosis Therapeutics Revenue Market Share, 2018-2029
5 Sights by Distribution Channel
    5.1 Overview
        5.1.1 By Distribution Channel - Global Multiple Sclerosis Therapeutics Market Size, 2022 & 2029
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 e-Commerce
    5.2 By Distribution Channel - Global Multiple Sclerosis Therapeutics Revenue & Forecasts
        5.2.1 By Distribution Channel - Global Multiple Sclerosis Therapeutics Revenue, 2018-2023
        5.2.2 By Distribution Channel - Global Multiple Sclerosis Therapeutics Revenue, 2024-2029
        5.2.3 By Distribution Channel - Global Multiple Sclerosis Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Multiple Sclerosis Therapeutics Market Size, 2022 & 2029
    6.2 By Region - Global Multiple Sclerosis Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Multiple Sclerosis Therapeutics Revenue, 2018-2023
        6.2.2 By Region - Global Multiple Sclerosis Therapeutics Revenue, 2024-2029
        6.2.3 By Region - Global Multiple Sclerosis Therapeutics Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Multiple Sclerosis Therapeutics Revenue, 2018-2029
        6.3.2 US Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.3.3 Canada Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.3.4 Mexico Multiple Sclerosis Therapeutics Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Multiple Sclerosis Therapeutics Revenue, 2018-2029
        6.4.2 Germany Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.4.3 France Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.4.4 U.K. Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.4.5 Italy Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.4.6 Russia Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.4.7 Nordic Countries Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.4.8 Benelux Multiple Sclerosis Therapeutics Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Multiple Sclerosis Therapeutics Revenue, 2018-2029
        6.5.2 China Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.5.3 Japan Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.5.4 South Korea Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.5.5 Southeast Asia Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.5.6 India Multiple Sclerosis Therapeutics Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Multiple Sclerosis Therapeutics Revenue, 2018-2029
        6.6.2 Brazil Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.6.3 Argentina Multiple Sclerosis Therapeutics Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Multiple Sclerosis Therapeutics Revenue, 2018-2029
        6.7.2 Turkey Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.7.3 Israel Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.7.4 Saudi Arabia Multiple Sclerosis Therapeutics Market Size, 2018-2029
        6.7.5 UAE Multiple Sclerosis Therapeutics Market Size, 2018-2029
7 Multiple Sclerosis Therapeutics Companies Profiles
    7.1 Novartis
        7.1.1 Novartis Company Summary
        7.1.2 Novartis Business Overview
        7.1.3 Novartis Multiple Sclerosis Therapeutics Major Product Offerings
        7.1.4 Novartis Multiple Sclerosis Therapeutics Revenue in Global Market (2018-2023)
        7.1.5 Novartis Key News & Latest Developments
    7.2 Teva Pharmaceuticals
        7.2.1 Teva Pharmaceuticals Company Summary
        7.2.2 Teva Pharmaceuticals Business Overview
        7.2.3 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Major Product Offerings
        7.2.4 Teva Pharmaceuticals Multiple Sclerosis Therapeutics Revenue in Global Market (2018-2023)
        7.2.5 Teva Pharmaceuticals Key News & Latest Developments
    7.3 Sanofi Genzyme
        7.3.1 Sanofi Genzyme Company Summary
        7.3.2 Sanofi Genzyme Business Overview
        7.3.3 Sanofi Genzyme Multiple Sclerosis Therapeutics Major Product Offerings
        7.3.4 Sanofi Genzyme Multiple Sclerosis Therapeutics Revenue in Global Market (2018-2023)
        7.3.5 Sanofi Genzyme Key News & Latest Developments
    7.4 Bayer
        7.4.1 Bayer Company Summary
        7.4.2 Bayer Business Overview
        7.4.3 Bayer Multiple Sclerosis Therapeutics Major Product Offerings
        7.4.4 Bayer Multiple Sclerosis Therapeutics Revenue in Global Market (2018-2023)
        7.4.5 Bayer Key News & Latest Developments
    7.5 Pfizer
        7.5.1 Pfizer Company Summary
        7.5.2 Pfizer Business Overview
        7.5.3 Pfizer Multiple Sclerosis Therapeutics Major Product Offerings
        7.5.4 Pfizer Multiple Sclerosis Therapeutics Revenue in Global Market (2018-2023)
        7.5.5 Pfizer Key News & Latest Developments
    7.6 Biogen Idec
        7.6.1 Biogen Idec Company Summary
        7.6.2 Biogen Idec Business Overview
        7.6.3 Biogen Idec Multiple Sclerosis Therapeutics Major Product Offerings
        7.6.4 Biogen Idec Multiple Sclerosis Therapeutics Revenue in Global Market (2018-2023)
        7.6.5 Biogen Idec Key News & Latest Developments
    7.7 Merck
        7.7.1 Merck Company Summary
        7.7.2 Merck Business Overview
        7.7.3 Merck Multiple Sclerosis Therapeutics Major Product Offerings
        7.7.4 Merck Multiple Sclerosis Therapeutics Revenue in Global Market (2018-2023)
        7.7.5 Merck Key News & Latest Developments
    7.8 AbbVie
        7.8.1 AbbVie Company Summary
        7.8.2 AbbVie Business Overview
        7.8.3 AbbVie Multiple Sclerosis Therapeutics Major Product Offerings
        7.8.4 AbbVie Multiple Sclerosis Therapeutics Revenue in Global Market (2018-2023)
        7.8.5 AbbVie Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Multiple Sclerosis Therapeutics Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?